June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that ... improve the early diagnosis and management of a wide range of debilitating ...

The INTERCEPT study is being funded to the tune of €38 million (nearly $40 million) over the next five years and is described ...

Eating a Mediterranean-style diet can help people manage IBD symptoms, and a new cookbook from Crohn's & Colitis Ireland ...

Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...

Discover how the Mediterranean diet benefits newly diagnosed Crohn’s disease patients by reducing inflammation and improving ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Many with Crohn’s disease or ulcerative colitis sacrifice essential purchases like food and clothing for healthcare, survey ...

Takeda is serving as the Industry Lead in the newly launched INTERCEPT project to identify predictive biomarkers for Crohn's ...

The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...

Both Crohn’s disease and ulcerative colitis involve ... are common in IBD patients and can complicate the diagnosis and management of the condition. Symptoms of IBD can be varied and impact ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...